The Pharmaceutical Industry is facing significant challenges that have prompted a shift from focusing on the use of internal resources for the vigorous pursuit of intellectual property to a new paradigm with increased exploration of pre-competitive, cross-industry collaboration, as well as an increasing engagement with the public domain. The Pistoia Alliance is working to streamline non-competitive elements of the pharmaceutical drug discovery workflow by the specification of common business terms, relationships and processes. The Pharma Industry emphasis on externalization and sourcing, development of common standards and a service orientation will underpin the decoupling of data from proprietary technologies necessary for the success of this work. Several examples of emergent collaborations will be highlighted, with an emphasis on expanding consortia to deliver new high quality pre-competitive resources in the public domain.

SPEAKER:
Cory R. Brouwer, Ph.D. is part of Pfizer's Computational Sciences Centre of Emphasis and is Co-Chair of the Knowledge and Information Services Domain within Pistoia.

BIOGRAPHY:
Cory R. Brouwer, Ph.D. is part of Pfizer's Computational Sciences Centre of Emphasis which focuses on the development of novel computational methods and algorithms to improve drug target selection. He has been involved with Pistoia almost from the beginning and is Co-Chair of the Knowledge and Information Services Domain within Pistoia. He is also active in other pre-competitive collaborations such as the EBI Industry Forum and co-authored the Nature Reviews Drug Discovery paper "Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery" last year with Barnes, et al.